Literature DB >> 17715386

Functional characterization of testis-specific rodent multidrug and toxic compound extrusion 2, a class III MATE-type polyspecific H+/organic cation exporter.

Miki Hiasa1, Takuya Matsumoto, Toshinori Komatsu, Hiroshi Omote, Yoshinori Moriyama.   

Abstract

Mammalian multidrug and toxic compound extrusion (MATE) proteins are classified into three subfamilies: classes I, II, and III. We previously showed that two of these families act as polyspecific H(+)-coupled transporters of organic cations (OCs) at final excretion steps in liver and kidney (Otsuka et al. Proc Natl Acad Sci USA 102: 17923-17928, 2005; Omote et al. Trends Pharmacol Sci 27: 587-593, 2006). Rodent MATE2 proteins are class III MATE transporters, the molecular nature, as well as transport properties, of which remain to be characterized. In the present study, we investigated the transport properties and localization of mouse MATE2 (mMATE2). On expression in human embryonic kidney (HEK)-293 cells, mMATE2 localized to the intracellular organelles and plasma membrane. mMATE2 mediated pH-dependent TEA transport with substrate specificity similar to, but distinct from, that of mMATE1, which prefers N-methylnicotinamide and guanidine as substrates. mMATE2 expressed in insect cells was solubilized and reconstituted with bacterial H(+)-ATPase into liposomes. The resultant proteoliposomes exhibited ATP-dependent uptake of TEA that was sensitive to carbonyl cyanide 3-chlorophenylhydrazone but unaffected by valinomycin in the presence of K(+). Immunologic techniques using specific antibodies revealed that mMATE2 was specifically expressed in testicular Leydig cells. Thus mMATE2 appears to act as a polyspecific H(+)/OC exporter in Leydig cells. It is concluded that all classes of mammalian MATE proteins act as polyspecific and electroneutral transporters of organic cations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17715386     DOI: 10.1152/ajpcell.00280.2007

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  9 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 2.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

Review 3.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  MATE1 has an external COOH terminus, consistent with a 13-helix topology.

Authors:  Xiaohong Zhang; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-10

Review 5.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

6.  Characterization of MATE-type multidrug efflux pumps from Klebsiella pneumoniae MGH78578.

Authors:  Wakano Ogawa; Yusuke Minato; Hayata Dodan; Motoyasu Onishi; Tomofusa Tsuchiya; Teruo Kuroda
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

7.  The first characterization of multidrug and toxin extrusion (MATE/SLC47) proteins in zebrafish (Danio rerio).

Authors:  Jovica Lončar; Marta Popović; Petra Krznar; Roko Zaja; Tvrtko Smital
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

8.  Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters.

Authors:  Temdara Tun; Young-Sook Kang
Journal:  Biomol Ther (Seoul)       Date:  2017-07-01       Impact factor: 4.634

9.  MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia.

Authors:  Muhammad Erfan Uddin; Eric D Eisenmann; Yang Li; Kevin M Huang; Dominique A Garrison; Zahra Talebi; Alice A Gibson; Yan Jin; Mahesh Nepal; Ingrid M Bonilla; Qiang Fu; Xinxin Sun; Alec Millar; Mikhail Tarasov; Christopher E Jay; Xiaoming Cui; Heidi J Einolf; Ryan M Pelis; Sakima A Smith; Przemysław B Radwański; Douglas H Sweet; Jörg König; Martin F Fromm; Cynthia A Carnes; Shuiying Hu; Alex Sparreboom
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.